BioGaia AB (publ) (STO:BIOG.B)

Market Cap	10.21B
Revenue (ttm)	1.42B
Net Income (ttm)	309.74M
Shares Out	101.16M
EPS (ttm)	3.06
PE Ratio	32.97
Forward PE	25.94
Dividend	6.90 (6.84%)
Ex-Dividend Date	May 8, 2025

Volume	186,531
Average Volume	187,728
Open	101.10
Previous Close	100.90
Day's Range	98.80 - 101.80
52-Week Range	93.50 - 139.70
Beta	0.65
RSI	43.19
Earnings Date	Jul 18, 2025

About BioGaia AB

BioGaia AB (publ), a healthcare company, provides probiotic products worldwide. The company operates through Pediatrics, Adult Health, and Other segments. The Pediatrics segment offers drops, oral rehydration solutions, and gut health tablets, as well as cultures that are used as an ingredient in infant formula and milk formula. The Adult Health segment provides gut health tablets, bone health tablets and oral health lozenges, as well as cultures, which are used as an ingredient in a licensee’s dairy product. The Other segment provides packagin...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1990
• Employees: 225
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: BIOG.B

Financial Performance

In 2024, BioGaia AB's revenue was 1.42 billion, an increase of 9.73% compared to the previous year's 1.30 billion. Earnings were 351.39 million, a decrease of -3.82%.